Damora Therapeutics (DMRA) Retained Earnings (2019 - 2026)
Damora Therapeutics (DMRA) reported Retained Earnings of $754000.0 for Q1 2026, up 151.33% on a YoY basis from $300000.0 in Q1 2025, and down 5.99% quarter-over-quarter from $802000.0 in Q4 2025.
Damora Therapeutics (DMRA) Retained Earnings (2019 - 2026) Analysis & Trends
Damora Therapeutics has reported Retained Earnings for 8 years, with the latest figure at $754000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 151.33% year-over-year to $754000.0; the trailing twelve-month figure through Mar 2026 stood at $754000.0 (up 151.33% YoY), and the FY2025 full-year result was $802000.0, up 726.8% from the prior year.
- Retained Earnings for Q1 2026 stood at $754000.0, down from $802000.0 in the prior quarter.
- The five-year high for Retained Earnings was $809000.0 in Q2 2025, with the low at -$286.6 million in Q3 2025.
- Historically, Retained Earnings has averaged -$112.6 million across 5 years, with a median of -$695000.0 in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings sank 228776.4% — and 2025, when it surged 726.8%.
- Damora Therapeutics' Retained Earnings stood at -$217.7 million in 2022, then soared by 100.17% to $380000.0 in 2023, then sank by 74.47% to $97000.0 in 2024, then surged by 726.8% to $802000.0 in 2025, then fell by 5.99% to $754000.0 in 2026.
- The last three Retained Earnings figures came in at $754000.0 (Q1 2026), $802000.0 (Q4 2025), and -$286.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Damora Therapeutics | 731.26 Mn | 528.86 Mn | - | 754,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 754,000.00 |
| Dec 31, 2025 | 802,000.00 |
| Sep 30, 2025 | -286.60 Mn |
| Jun 30, 2025 | 809,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | -270.78 Mn |
| Jun 30, 2024 | -266.90 Mn |
| Mar 31, 2024 | 326,000.00 |
| Dec 31, 2023 | 380,000.00 |
| Sep 30, 2023 | -249.61 Mn |
| Jun 30, 2023 | -137,000.00 |
| Mar 31, 2023 | -230.73 Mn |
| Dec 31, 2022 | -217.74 Mn |
| Sep 30, 2022 | -203.70 Mn |
| Jun 30, 2022 | -189.94 Mn |
| Mar 31, 2022 | -695,000.00 |
| Dec 31, 2021 | -320,000.00 |
| Sep 30, 2021 | -89,000.00 |
| Jun 30, 2021 | -130.01 Mn |